MTOR and cancer: Dysregulation of the phosphoinositide 3-kinase/protein kinase B/mammalian target of rapamycin (PI3K/AKT/mTOR) signaling pathway, a consistent feature of malignant tumors, is intricately linked to ROS generation [137].